Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Chengyang Chen, Xia Jiang & Zengren Zhao. (2023) Inhibition or promotion, the potential role of arginine metabolism in immunotherapy for colorectal cancer. All Life 16:1.
Read now
Read now
Yuan Fang, Gang Yang, Jinshou Yang, Jie Ren, Lei You & Yupei Zhao. (2023) Human microbiota colonization and pancreatic ductal carcinoma. Critical Reviews in Microbiology 49:4, pages 455-468.
Read now
Read now
Meng-ke Fan, Li-li Qi, Qi Zhang & Ling Wang. (2021) The Updated Status and Future Direction of Immunotherapy Targeting B7-H1/PD-1 in Osteosarcoma. Cancer Management and Research 13, pages 757-764.
Read now
Read now
Ming-Xi Liu, Qing-Yu Liu, Ye Liu, Zhi-Ming Cheng, Lei Liu, Lei Zhang & Da-Hui Sun. (2019) Interleukin-35 suppresses antitumor activity of circulating CD8+ T cells in osteosarcoma patients. Connective Tissue Research 60:4, pages 367-375.
Read now
Read now
Articles from other publishers (46)
Yuxing Chen, Jinhang He, Tian Jin, Ye Zhang & Yunsheng Ou. (2023) Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma. Journal of Cancer Research and Clinical Oncology 149:18, pages 16905-16929.
Crossref
Crossref
Liming Liao, Huilin Xu, Yuhan Zhao & Xiaofeng Zheng. (2023) Metabolic interventions combined with CTLA-4 and PD-1/PD-L1 blockade for the treatment of tumors: mechanisms and strategies. Frontiers of Medicine.
Crossref
Crossref
Shijing You, Xiahui Han, Yuance Xu & Qin Yao. (2023) Research progress on the role of cationic amino acid transporter (CAT) family members in malignant tumors and immune microenvironment. Amino Acids 55:10, pages 1213-1222.
Crossref
Crossref
Kyra Laubach, Tolga Turan, Rebecca Mathew, Julie Wilsbacher, John Engelhardt & Josue Samayoa. (2023) Tumor-intrinsic metabolic reprogramming and how it drives resistance to anti-PD-1/PD-L1 treatment. Cancer Drug Resistance 6:3, pages 611-41.
Crossref
Crossref
Jianguo Lai, Yuchen Cao, Jiexin Zhang, Jinglong Wang, Yawen Du, Yan He, Yuting Luo & Ning Liao. (2023) Machine Learning and Pan‐Cancer Analysis of Tertiary Lymphoid Structures: A Potential Target for Survival and Drug Treatment. Advanced Therapeutics 6:9.
Crossref
Crossref
Hui Ying, Zhi-Qiang Li, Meng-Pan Li & Wen-Cai Liu. (2023) Metabolism and senescence in the immune microenvironment of osteosarcoma: focus on new therapeutic strategies. Frontiers in Endocrinology 14.
Crossref
Crossref
Julio José Jiménez-Alonso & Miguel López-Lázaro. (2023) Dietary Manipulation of Amino Acids for Cancer Therapy. Nutrients 15:13, pages 2879.
Crossref
Crossref
Wentao Feng, Mingrong Zuo, Wenhao Li, Siliang Chen, Zhihao Wang, Yunbo Yuan, Yuan Yang & Yanhui Liu. (2023) A novel score system based on arginine metabolism-related genes to predict prognosis, characterize immune microenvironment, and forecast response to immunotherapy in IDH-wildtype glioblastoma. Frontiers in Pharmacology 14.
Crossref
Crossref
Hailong Tian, Jiangjun Cao, Bowen Li, Edouard C. Nice, Haijiao Mao, Yi Zhang & Canhua Huang. (2023) Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment. Bone Research 11:1.
Crossref
Crossref
Pratibha Pandey, Fahad Khan, Tarun Kumar Upadhyay & Ramish Maqsood. (2023) Review to Understand the Crosstalk between Immunotherapy and Tumor Metabolism. Molecules 28:2, pages 862.
Crossref
Crossref
Claudia Maria Hattinger, Iris Chiara Salaroglio, Leonardo Fantoni, Martina Godel, Chiara Casotti, Joanna Kopecka, Katia Scotlandi, Toni Ibrahim, Chiara Riganti & Massimo Serra. (2023) Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma. International Journal of Molecular Sciences 24:1, pages 799.
Crossref
Crossref
Jie Zang, Yushan Yang, Xiao Zheng, Yan Yang, Yuge Zhao, Zhe Miao, Tingting Zhang, Jingjing Gu, Yiqiong Liu, Weimin Yin, Xiaoyi Ma, Quanming Ding, Haiqing Dong, Yan Li & Yongyong Li. (2023) Dynamic tagging to drive arginine nano-assembly to metabolically potentiate immune checkpoint blockade therapy. Biomaterials 292, pages 121938.
Crossref
Crossref
Chenyue Zhang, Xiaoling Shang & Haiyong Wang. (2022) Untargeted metabolomics and lipidomics identified four subtypes of small cell lung cancer. Metabolomics 19:1.
Crossref
Crossref
Yi Wang, Yuya Wang, Yifei Ren, Qi Zhang, Ping Yi & Chunming Cheng. (2022) Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer. Seminars in Cancer Biology 86, pages 542-565.
Crossref
Crossref
Arpita Poddar, Sushma R. Rao, Prashanth Prithviraj, George Kannourakis & Aparna Jayachandran. (2022) Crosstalk between Immune Checkpoint Modulators, Metabolic Reprogramming and Cellular Plasticity in Triple-Negative Breast Cancer. Current Oncology 29:10, pages 6847-6863.
Crossref
Crossref
Xuanyu Zhu, Longfei Zhu & Yan Wu. (2022) Manipulating Metabolic Alterations and their Consequences to Unleash the Potential of Antitumor Immunotherapy. Current Protein & Peptide Science 23:9, pages 585-601.
Crossref
Crossref
Junlei Zhang, Sijie Wang, Xuemeng Guo, Yichao Lu, Xu Liu, Mengshi Jiang, Xiang Li, Bing Qin, Zhenyu Luo, Huihui Liu, Qingpo Li, Yong-Zhong Du, Lihua Luo & Jian You. (2022) Arginine Supplementation Targeting Tumor-Killing Immune Cells Reconstructs the Tumor Microenvironment and Enhances the Antitumor Immune Response. ACS Nano 16:8, pages 12964-12978.
Crossref
Crossref
Qili Shi, Yizhe Liu, Mingxing Lu, Qun-Ying Lei, Zhiao Chen, Lu Wang & Xianghuo He. (2022) A pathway-guided strategy identifies a metabolic signature for prognosis prediction and precision therapy for hepatocellular carcinoma. Computers in Biology and Medicine 144, pages 105376.
Crossref
Crossref
Jinfen Wei, Meiling Hu & Hongli Du. (2022) Improving Cancer Immunotherapy: Exploring and Targeting Metabolism in Hypoxia Microenvironment. Frontiers in Immunology 13.
Crossref
Crossref
Hee-Chan Yoo & Jung-Min Han. (2022) Amino Acid Metabolism in Cancer Drug Resistance. Cells 11:1, pages 140.
Crossref
Crossref
Racheal Johnson, Michele Cummings, Amudha Thangavelu, Georgios Theophilou, Diederick de Jong & Nicolas Orsi. (2021) Barriers to Immunotherapy in Ovarian Cancer: Metabolic, Genomic, and Immune Perturbations in the Tumour Microenvironment. Cancers 13:24, pages 6231.
Crossref
Crossref
Huakan Zhao & Yongsheng Li. (2021) Cancer metabolism and intervention therapy. Molecular Biomedicine 2:1.
Crossref
Crossref
Ilaria Elia. (2021) Integrating metabolic engineering and immunotherapy. Current Opinion in Systems Biology 28, pages 100361.
Crossref
Crossref
Fernando P. Canale, Camilla Basso, Gaia Antonini, Michela Perotti, Ning Li, Anna Sokolovska, Julia Neumann, Michael J. James, Stefania Geiger, Wenjie Jin, Jean-Philippe Theurillat, Kip A. West, Daniel S. Leventhal, Jose M. Lora, Federica Sallusto & Roger Geiger. (2021) Metabolic modulation of tumours with engineered bacteria for immunotherapy. Nature 598:7882, pages 662-666.
Crossref
Crossref
Lin Xiao, Harrison Yeung, Michelle Haber, Murray D. Norris & Klaartje Somers. (2021) Immunometabolism: A ‘Hot’ Switch for ‘Cold’ Pediatric Solid Tumors. Trends in Cancer 7:8, pages 751-777.
Crossref
Crossref
Erica Pranzini, Elisa Pardella, Paolo Paoli, Sarah-Maria Fendt & Maria Letizia Taddei. (2021) Metabolic Reprogramming in Anticancer Drug Resistance: A Focus on Amino Acids. Trends in Cancer 7:8, pages 682-699.
Crossref
Crossref
Qi Wu, Xin Yu, Juanjuan Li, Shengrong Sun & Yi Tu. (2021) Metabolic regulation in the immune response to cancer. Cancer Communications 41:8, pages 661-694.
Crossref
Crossref
Adrià-Arnau Martí i Líndez & Walter Reith. (2021) Arginine-dependent immune responses. Cellular and Molecular Life Sciences 78:13, pages 5303-5324.
Crossref
Crossref
Lindsay Jones Talbot, Ashley Chabot, Amy Funk, Phuong Nguyen, Jessica Wagner, Aaron Ross, Heather Tillman, Andrew Davidoff, Stephen Gottschalk & Christopher DeRenzo. (2021) A Novel Orthotopic Implantation Technique for Osteosarcoma Produces Spontaneous Metastases and Illustrates Dose-Dependent Efficacy of B7-H3-CAR T Cells. Frontiers in Immunology 12.
Crossref
Crossref
Veronica Romano, Immacolata Belviso, Alessandro Venuta, Maria Rosaria Ruocco, Stefania Masone, Federica Aliotta, Giuseppe Fiume, Stefania Montagnani, Angelica Avagliano & Alessandro Arcucci. (2021) Influence of Tumor Microenvironment and Fibroblast Population Plasticity on Melanoma Growth, Therapy Resistance and Immunoescape. International Journal of Molecular Sciences 22:10, pages 5283.
Crossref
Crossref
Marie‐Françoise Heymann, Kristina Schiavone & Dominique Heymann. (2020) Bone sarcomas in the immunotherapy era. British Journal of Pharmacology 178:9, pages 1955-1972.
Crossref
Crossref
Weiming Yang, Weiheng Zhang, Xiaozhong Wang, Liming Tan, Hua Li, Jiemin Wu, Qiong Wu, Wanlei Sun, Juanjuan Chen & Yanhui Yin. (2021) HCA587 Protein Vaccine Induces Specific Antitumor Immunity Mediated by CD4+ T-cells Expressing Granzyme B in a Mouse Model of Melanoma. Anti-Cancer Agents in Medicinal Chemistry 21:6, pages 738-746.
Crossref
Crossref
Chenglong Chen, Lu Xie, Tingting Ren, Yi Huang, Jie Xu & Wei Guo. (2021) Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs. Cancer Letters 500, pages 1-10.
Crossref
Crossref
Alok Kumar & Kenji Chamoto. (2021) Immune metabolism in PD-1 blockade-based cancer immunotherapy. International Immunology 33:1, pages 17-26.
Crossref
Crossref
Barbara Érsek, Pálma Silló, Ugur Cakir, Viktor Molnár, András Bencsik, Balázs Mayer, Eva Mezey, Sarolta Kárpáti, Zoltán Pós & Krisztián Németh. (2020) Melanoma-associated fibroblasts impair CD8+ T cell function and modify expression of immune checkpoint regulators via increased arginase activity. Cellular and Molecular Life Sciences 78:2, pages 661-673.
Crossref
Crossref
Md Amir Hossain, Guilai Liu, Beiying Dai, Yaxuan Si, Qitao Yang, Junaid Wazir, Lutz Birnbaumer & Yong Yang. (2020)
Reinvigorating exhausted CD8
+
cytotoxic T lymphocytes in the tumor microenvironment and current strategies in cancer immunotherapy
. Medicinal Research Reviews 41:1, pages 156-201.
Crossref
Crossref
Jane Koo, Masanori Hayashi, Michael R. Verneris & Alisa B. Lee-Sherick. (2020) Targeting Tumor-Associated Macrophages in the Pediatric Sarcoma Tumor Microenvironment. Frontiers in Oncology 10.
Crossref
Crossref
Weimin Wang & Weiping Zou. (2020) Amino Acids and Their Transporters in T Cell Immunity and Cancer Therapy. Molecular Cell 80:3, pages 384-395.
Crossref
Crossref
Suyin Ge, Qingqing Zhang, Yizhen Tian, Luyang Hao, Jingru Duan & Baolai Zhang. (2020) Cell metabolic profiling of colorectal cancer via 1H NMR. Clinica Chimica Acta 510, pages 291-297.
Crossref
Crossref
Jingjing Fan, Ziyuan Feng & Ning Chen. (2020) Spermidine as a target for cancer therapy. Pharmacological Research 159, pages 104943.
Crossref
Crossref
Yusuke Satoh, Hitoshi Kotani, Yuichi Iida, Takahito Taniura, Yoshitomo Notsu & Mamoru Harada. (2020)
Supplementation of
l
‐arginine boosts the therapeutic efficacy of anticancer chemoimmunotherapy
. Cancer Science 111:7, pages 2248-2258.
Crossref
Crossref
Adrià-Arnau Martí Líndez, Isabelle Dunand-Sauthier, Mark Conti, Florian Gobet, Nicolás Núñez, J. Thomas Hannich, Howard Riezman, Roger Geiger, Alessandra Piersigilli, Kerstin Hahn, Sylvain Lemeille, Burkhard Becher, Thibaut De Smedt, Stéphanie Hugues & Walter Reith. (2019) Mitochondrial arginase-2 is a cell‑autonomous regulator of CD8+ T cell function and antitumor efficacy. JCI Insight 4:24.
Crossref
Crossref
Xiaoyun Li, Mathias Wenes, Pedro Romero, Stanley Ching-Cheng Huang, Sarah-Maria Fendt & Ping-Chih Ho. (2019) Navigating metabolic pathways to enhance antitumour immunity and immunotherapy. Nature Reviews Clinical Oncology 16:7, pages 425-441.
Crossref
Crossref
David O’Sullivan, David E. Sanin, Edward J. Pearce & Erika L. Pearce. (2019) Metabolic interventions in the immune response to cancer. Nature Reviews Immunology 19:5, pages 324-335.
Crossref
Crossref
Rebecca Hesterberg, John Cleveland & Pearlie Epling-Burnette. (2018) Role of Polyamines in Immune Cell Functions. Medical Sciences 6:1, pages 22.
Crossref
Crossref
Hong Sun, Xiaoguang Han, Xiuhui Yan, Jingli Xu, Qiujing Huang, Fanqing Meng, Hongjin Zhang & Shufa Li. (2017) A novel mimovirus encoding ChgA 10–19 peptide with PD-L1 induces T cell tolerance and ameliorates the severity of diabetes. Cellular Immunology 320, pages 56-61.
Crossref
Crossref